MGO One Seven LLC Purchases 613 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MGO One Seven LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,706 shares of the healthcare conglomerate’s stock after buying an additional 613 shares during the quarter. MGO One Seven LLC’s holdings in UnitedHealth Group were worth $4,943,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. Coldstream Capital Management Inc. raised its position in shares of UnitedHealth Group by 1.9% during the 2nd quarter. Coldstream Capital Management Inc. now owns 25,095 shares of the healthcare conglomerate’s stock valued at $12,780,000 after purchasing an additional 471 shares during the period. Eubel Brady & Suttman Asset Management Inc. lifted its holdings in UnitedHealth Group by 28.0% in the 2nd quarter. Eubel Brady & Suttman Asset Management Inc. now owns 938 shares of the healthcare conglomerate’s stock worth $478,000 after purchasing an additional 205 shares in the last quarter. Gryphon Financial Partners LLC grew its holdings in UnitedHealth Group by 16.8% during the 2nd quarter. Gryphon Financial Partners LLC now owns 5,855 shares of the healthcare conglomerate’s stock valued at $2,982,000 after buying an additional 841 shares in the last quarter. Malaga Cove Capital LLC bought a new position in shares of UnitedHealth Group during the second quarter worth $313,000. Finally, Seaview Investment Managers LLC increased its holdings in UnitedHealth Group by 23.4% in the 2nd quarter. Seaview Investment Managers LLC now owns 19,275 shares of the healthcare conglomerate’s stock valued at $9,816,000 after acquiring an additional 3,653 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. TD Cowen lifted their target price on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Trading Up 0.8 %

Shares of UNH opened at $599.04 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market capitalization of $553.17 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 1.66 and a beta of 0.58. The company has a 50-day moving average of $562.99 and a 200 day moving average of $516.05. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $607.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period last year, the business posted $6.14 EPS. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.40%. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.